Literature DB >> 25251883

Dorzolamide-induced relaxation of porcine retinal arterioles in vitro depends on nitric oxide but not on acidosis in vascular smooth muscle cells.

A El-Galaly1, C Aalkjaer2, S K Kringelholt3, M W Misfeldt3, T Bek3.   

Abstract

The carbonic anhydrase inhibitor dorzolamide can induce relaxation of retinal arterioles with a consequent increase in blood flow and oxygenation of the retina. It has been shown that the mechanisms underlying this relaxation are independent of extracellular acidosis and CO2. The purpose of the present study was to investigate the possible involvement of nitric oxide (NO) and intracellular acidosis in dorzolamide-induced relaxation of retinal arterioles. Porcine retinal arterioles were mounted in a wire myograph and dorzolamide induced relaxation was studied after 1) the addition of the NO synthase inhibitor l-NAME (3 × 10(-4) M) or the guanylyl cyclase inhibitor ODQ (3 × 10(-6) M), and 2) after loading the smooth muscle cells with the pH sensitive fluorophore SNARF-1-AM and studying changes in vascular tone and intracellular fluorescence after the induction of hypoxia, addition of lactate (10(-2) M), and extracellular acidification (pH = 7.0) alone and in the presence of dorzolamide (10(-3) M). Dorzolamide significantly relaxed retinal arterioles (p < 0.03), and the effect was significantly higher in the presence of perivascular tissue than in isolated vessels at the highest concentration (p < 0.01). In the presence of perivascular tissue dorzolamide-induced relaxation could be reduced by NO inhibition (p < 0.02). Dorzolamide increased intracellular acidification (p < 0.02) during extracellular acidosis, but there was no relation between relaxation and intracellular acidosis. In conclusion, dorzolamide-induced vasorelaxation depends on NO and the perivascular retinal tissue, but is independent of acidification in the extracellular and the intracellular space of retinal vascular smooth muscle cells. Other factors than NO and acidification are involved in dorzolamide-induced relaxation of retinal arterioles.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Carbonic anhydrase inhibitors; Dorzolamide; Intracellular acidosis; Nitric oxide; Relaxation; Retina

Mesh:

Substances:

Year:  2014        PMID: 25251883     DOI: 10.1016/j.exer.2014.09.006

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  6 in total

1.  The diameter response of retinal arterioles in diabetic maculopathy is reduced during hypoxia and is unaffected by the inhibition of cyclo-oxygenase and nitric oxide synthesis.

Authors:  Line Petersen; Toke Bek
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-06-07       Impact factor: 3.117

2.  Carbonic anhydrase inhibitors modify intracellular pH transients and contractions of rat middle cerebral arteries during CO2/HCO3- fluctuations.

Authors:  Jacob K Rasmussen; Ebbe Boedtkjer
Journal:  J Cereb Blood Flow Metab       Date:  2017-03-20       Impact factor: 6.200

3.  Dorzolamide-induced relaxation of isolated rabbit ciliary arteries mediated by inhibition of extracellular calcium influx.

Authors:  Yaru Dong; Yu Sawada; Jizhe Cui; Masahiro Hayakawa; Dai Ogino; Makoto Ishikawa; Takeshi Yoshitomi
Journal:  Jpn J Ophthalmol       Date:  2016-01-12       Impact factor: 2.447

4.  Post-hypoxic constriction of retinal arterioles is impaired during nitric oxide and cyclo-oxygenase inhibition and in diabetic patients without retinopathy.

Authors:  Line Petersen; Toke Bek
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-07-27       Impact factor: 3.117

Review 5.  Acid-base regulation and sensing: Accelerators and brakes in metabolic regulation of cerebrovascular tone.

Authors:  Ebbe Boedtkjer
Journal:  J Cereb Blood Flow Metab       Date:  2017-10-06       Impact factor: 6.200

Review 6.  Dorzolamide/Timolol Fixed Combination: Learning from the Past and Looking Toward the Future.

Authors:  Anastasios G Konstas; Leopold Schmetterer; Andreas Katsanos; Cindy M L Hutnik; Gábor Holló; Luciano Quaranta; Miguel A Teus; Hannu Uusitalo; Norbert Pfeiffer; L Jay Katz
Journal:  Adv Ther       Date:  2020-10-27       Impact factor: 3.845

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.